Physician profile
Kyle Rickards
NPI 1144829425
$5,054.78
in general payments reported to CMS, 2019-2025
15 companies · $2,081 in 2025
The $2,081 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $286 · 2023: $448 · 2024: $2,008 · 2025: $2,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,684 · Travel and Lodging: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,684.44 |
| Travel and Lodging | $1,852.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,943.68 | 2024-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $980.81 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Nevro Corp. | $580.38 | 2021-2024 | Senza |
| Abbvie INC. | $477.10 | 2021-2025 | |
| Saluda Medical Americas, INC. | $409.13 | 2024-2025 | Evoke |
| Collegium Pharmaceutical, INC. | $268.93 | 2022-2025 | Belbuca, Xtampza |
| Azurity Pharmaceuticals, INC. | $88.78 | 2023-2025 | Horizant, Horizant |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.14 | 2022-2025 | Relistor |
| Biohaven Pharmaceuticals, INC. | $70.15 | 2021 | |
| Si-Bone, INC. | $37.56 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $31.89 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $25.82 | 2025 | |
| Fidia Pharma USA INC. | $21.13 | 2025 | Hymovis |
| Kowa Pharmaceuticals America, INC. | $18.65 | 2022 | |
| Biodelivery Sciences International, INC. | $14.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Rickards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.